v3.10.0.1

Consolidated Balance Sheets - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Assets
Cash	$ 9,348
Total current assets	9,348
Total assets	9,348
Liabilities and Stockholders' Deficit
Accounts payable	423,705	$ 312,475
Accrued expenses and other liabilities	2,590,890	2,528,834
Deferred sales	93,326	92,516
Deferred rent	633	627
Capital lease obligation	10,368	10,368
Notes payable - related parties	1,704,785	1,633,222
Current portion of notes payable	70,403
Total current liabilities	4,894,110	4,578,042
Capital lease obligation	40,024	40,024
Total long-term liabilities	40,024	40,024
Total liabilities	4,934,134	4,618,066
Stockholders' deficit:
Common stock, $0.00001 par value, Authorized 450,000,000 shares, 322,872,175 and 309,522,175 shares issued and outstanding at March 31, 2017 and December 31, 2016, repectively	3,262	3,096
Additional paid-in capital	10,626,491	9,970,127
Retained earnings	(15,583,102)	(14,630,991)
Total stockholders' deficit	(4,924,786)	$ (4,618,066)
Total liabilities and stockholders' deficit	$ 9,348

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

EASTGATE BIOTECH CORP 10-Q/A